Amiloidózis: vizsgálatok itt: Japán
13 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleMAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Where
- Kumamoto, Osaka, Tokyo, Toyama
- Életkor
- 18 év to 90 év
- People
- 1200 worldwide
- Run by
- Intellia Therapeutics
See details and how to joinNCT06128629 · EU 2023-507220-23-00 - 1. fázisTaking peopleA Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
- Where
- Shibuya City, Suita-shi, Tokyo
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT05652335 · EU 2023-503679-12-00 - 3. fázisTaking peopleCLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
- Where
- Amagasaki, Bunkyo-ku, Fukuoka, Himeji, Kanagawa, Kashihara, Kitakyushu, Kobe, Kumamoto, Kurume-shi, Kyoto, Matsumoto, Nagasaki, Nagoya, Nankoku-shi, Osaka, Sapporo, Suita, Tokyo, Toyama, Tsu, Uwajima-shi, Yamaguchi Prefecture, Yokohama
- Életkor
- 18 év and over
- People
- 1280 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07207811 - 3. fázisTaking peopleTRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Where
- Bunkyō City, Fukuoka, Kagawa, Kashihara, Kobe, Kumamoto, Kurume, Matsumoto-shi, Nagoya, Nankoku, Niigata, Okayama, Sapporo, Sendai, Suita, Tokyo
- Életkor
- 18 év to 85 év
- People
- 1750 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT07052903 · EU 2024-519917-72-00 - No phaseTaking peopleDemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
- Where
- Bunkyō City, Kumamoto, Kurume, Matsumoto, Sendai, Shinjuku, Suita, Tsukuba, Ube, Yufu
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT07358078 - 3. fázisTaking peopleTRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
- Where
- Bunkyo C, Kumamoto, Matsumoto-shi, Suita
- Életkor
- 18 év to 85 év
- People
- 125 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT07223203 · EU 2025-522544-40-00 - No phaseTaking peopleOverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis
- Where
- Tokyo
- People
- 52 121 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06355934 - 3. fázisNot yet taking people in JapánAn Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy
- Where
- Bunkyo-ku, Kumamoto, Kurume-shi, Kyoto, Matsumoto-shi, Sapporo, Shinjuku-ku, Suita-shi
- People
- 1180 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT07789483 · EU 2026-526755-57-00 - 3. fázisTaking peopleAcoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Where
- Kumamoto, Nagano
- Életkor
- 18 év to 75 év
- People
- 587 worldwide
- Run by
- Eidos Therapeutics, a BridgeBio company
See details and how to joinNCT06563895 · EU 2024-513547-82-00 - 1/2. fázisTaking peopleA Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
- Where
- Kumamoto, Nagoya, Shibuya-ku
- Életkor
- 18 év and over
- People
- 76 worldwide
- Run by
- AbbVie
See details and how to joinNCT06158854 · EU 2023-503429-20-00 - 3. fázisCsak meghívásosAn Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
- Where
- Fukuoka, Hamamatsu, Kumamoto, Kurume, Kurume-shi, Matsumoto, Okayama, Osaka, Sapporo, Shinjuku-ku
- Életkor
- 18 év and over
- People
- 1400 worldwide
- Run by
- Ionis Pharmaceuticals, Inc.
See details and how to joinNCT05667493 - 4. fázisTaking peopleReal-Life Clinical Efficacy of Acoramidis in Participants With ATTR-CM and Association With Cardiac Biomarkers
- Where
- Bunkyō City, Kumamoto, Kurume-shi, Kyoto, Mitaka-shi, Nagoya, Nankoku-shi, Okayama, Ōtsu, Sagamihara-shi, Sapporo, Shinjuku-ku, Suita-shi, Tsu, Yufu-shi
- Életkor
- 18 év to 100 év
- People
- 200
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT07306949 - No phaseTaking peopleInternational Cardiac Amyloidosis Registry
- Where
- Sagamihara
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- Leiden University Medical Center
See details and how to joinNCT06894290